|
1. Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. 2008;117(21):2802-13. 2. Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med. 1979;300(14):772-7. 3. Marfan A. Un cas de deformation congenitale des quatres membres plus prononcee aux extremities characterisee par lallongement des os avec un certain degre d amincissement Bull Mem Soc Med Hop Paris. 1896;13:220. 4. Le E. Arachnodactyly complicated by dislocated lens and death from rupture of dissecting aneurysm of aorta. J Am Med Association. 1943;123(2):88-9. 5. Schorr S, Braun K, Wildman J. Congenital aneurysmal dilatation of the ascending aorta associated with arachnodactyly; an angiocardiographic study. Am Heart J. 1951;42(4):610-6. 6. Robinson PN, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet. 2000;37(1):9-25. 7. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312(5770):117-21. 8. Ng CM, Cheng A, Myers LA, et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest. 2004;114(11):1586-92. 9. Dormand H, Mohiaddin RH. Cardiovascular magnetic resonance in Marfan syndrome. J Cardiovasc Magn Reson. 2013;15:33. 10. Alpendurada F, Mohiaddin R. 1039 Prevalence of cardiovascular manifestations in patients with Marfan syndrome: a cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance. 2008;10(1):1-2. 11. Detaint D, Faivre L, Collod-Beroud G, et al. Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J. 2010;31(18):2223-9. 12. Beighton P, de Paepe A, Danks D, et al. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet. 1988;29(3):581-94. 13. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352(6333):337-9. 14. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;62(4):417-26. 15. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476-85. 16. Groth KA, Hove H, Kyhl K, et al. Prevalence, incidence, and age at diagnosis in Marfan Syndrome. Orphanet J Rare Dis. 2015;10:153. 17. Vasan RS, Larson MG, Levy D. Determinants of echocardiographic aortic root size. The Framingham Heart Study. Circulation. 1995;91(3):734-40. 18. Roman MJ, Rosen SE, Kramer-Fox R, Devereux RB. Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. J Am Coll Cardiol. 1993;22(5):1470-6. 19. Canadas V, Vilacosta I, Bruna I, Fuster V. Marfan syndrome. Part 1: pathophysiology and diagnosis. Nat Rev Cardiol. 2010;7(5):256-65. 20. Dietz HC, Loeys B, Carta L, Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am J Med Genet C Semin Med Genet. 2005;139C(1):4-9. 21. Tae HJ, Petrashevskaya N, Marshall S, Krawczyk M, Talan M. Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes. Am J Physiol Heart Circ Physiol. 2016;310(2):H290-9. 22. Kiotsekoglou A, Saha SK, Moggridge JC, et al. Effect of aortic stiffness on left ventricular long-axis systolic function in adults with Marfan syndrome. Hellenic J Cardiol. 2010;51(6):501-11. 23. Shiga T, Wajima Z, Apfel CC, Inoue T, Ohe Y. Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med. 2006;166(13):1350-6. 24. Kim SY, Wolfe DS, Taub CC. Cardiovascular outcomes of pregnancy in Marfan's syndrome patients: A literature review. Congenit Heart Dis. 2018;13(2):203-9. 25. Winther S, Williams LK, Keir M, et al. Cardiovascular Magnetic Resonance Provides Evidence of Abnormal Myocardial Strain and Primary Cardiomyopathy in Marfan syndrome. J Comput Assist Tomogr. 2019. 26. Oshinski JN, Parks WJ, Markou CP, et al. Improved measurement of pressure gradients in aortic coarctation by magnetic resonance imaging. J Am Coll Cardiol. 1996;28(7):1818-26. 27. Geiger J, Markl M, Herzer L, et al. Aortic flow patterns in patients with Marfan syndrome assessed by flow-sensitive four-dimensional MRI. J Magn Reson Imaging. 2012;35(3):594-600. 28. Wang HH, Chiu HH, Tseng WY, Peng HH. Does altered aortic flow in marfan syndrome relate to aortic root dilatation? J Magn Reson Imaging. 2016;44(2):500-8. 29. Silverman DI, Gray J, Roman MJ, et al. Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. J Am Coll Cardiol. 1995;26(4):1062-7. 30. Singh SD, Xu XY, Wood NB, et al. Aortic flow patterns before and after personalised external aortic root support implantation in Marfan patients. J Biomech. 2016;49(1):100-11. 31. Beller CJ, Labrosse MR, Thubrikar MJ, Robicsek F. Role of aortic root motion in the pathogenesis of aortic dissection. Circulation. 2004;109(6):763-9. 32. Beller CJ, Labrosse MR, Thubrikar MJ, Robicsek F. Finite element modeling of the thoracic aorta: including aortic root motion to evaluate the risk of aortic dissection. J Med Eng Technol. 2008;32(2):167-70. 33. Singh SD, Xu XY, Pepper JR, Izgi C, Treasure T, Mohiaddin RH. Effects of aortic root motion on wall stress in the Marfan aorta before and after personalised aortic root support (PEARS) surgery. J Biomech. 2016;49(10):2076-84. 34. Markl M, Frydrychowicz A, Kozerke S, Hope M, Wieben O. 4D flow MRI. J Magn Reson Imaging. 2012;36(5):1015-36. 35. Hennig J, Schneider B, Peschl S, Markl M, Krause T, Laubenberger J. Analysis of myocardial motion based on velocity measurements with a black blood prepared segmented gradient-echo sequence: methodology and applications to normal volunteers and patients. J Magn Reson Imaging. 1998;8(4):868-77. 36. Dyverfeldt P, Bissell M, Barker AJ, et al. 4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson. 2015;17:72. 37. von Knobelsdorff-Brenkenhoff F, Rudolph A, Wassmuth R, et al. Feasibility of cardiovascular magnetic resonance to assess the orifice area of aortic bioprostheses. Circ Cardiovasc Imaging. 2009;2(5):397-404, 2 p following 38. Mas-Stachurska A, Siegert AM, Batlle M, et al. Cardiovascular Benefits of Moderate Exercise Training in Marfan Syndrome: Insights From an Animal Model. J Am Heart Assoc. 2017;6(9). 39. Bock J, Frydrychowicz A, Lorenz R, et al. In vivo noninvasive 4D pressure difference mapping in the human aorta: phantom comparison and application in healthy volunteers and patients. Magn Reson Med. 2011;66(4):1079-88. 40. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303-11; discussion 12-3. 41. Devereux RB, de Simone G, Arnett DK, et al. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons >/=15 years of age. Am J Cardiol. 2012;110(8):1189-94. 42. Cook JR, Carta L, Benard L, et al. Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. J Clin Invest. 2014;124(3):1329-39. 43. Campens L, Renard M, Trachet B, et al. Intrinsic cardiomyopathy in Marfan syndrome: results from in-vivo and ex-vivo studies of the Fbn1C1039G/+ model and longitudinal findings in humans. Pediatr Res. 2015;78(3):256-63. 44. Ashikaga H, Criscione JC, Omens JH, Covell JW, Ingels NB, Jr. Transmural left ventricular mechanics underlying torsional recoil during relaxation. Am J Physiol Heart Circ Physiol. 2004;286(2):H640-7. 45. Jahren SE, Winkler BM, Heinisch PP, Wirz J, Carrel T, Obrist D. Aortic root stiffness affects the kinematics of bioprosthetic aortic valves. Interact Cardiovasc Thorac Surg. 2017;24(2):173-80. 46. Hundley WG, Kitzman DW, Morgan TM, et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol. 2001;38(3):796-802. 47. Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32(6):670-9. 48. Karagodin I, Aba-Omer O, Sparapani R, Strande JL. Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction. BMC Cardiovasc Disord. 2017;17(1):62. 49. Barker AJ, van Ooij P, Bandi K, et al. Viscous energy loss in the presence of abnormal aortic flow. Magn Reson Med. 2014;72(3):620-8. 50. Yi SX. [heart failure with preserved ejection fraction is a special type of heart failure]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45(6):482-4. 51. von Knobelsdorff-Brenkenhoff F, Hennig P, Menza M, et al. Myocardial dysfunction in patients with aortic stenosis and hypertensive heart disease assessed by MR tissue phase mapping. J Magn Reson Imaging. 2016;44(1):168-77. 52. Harrison MR, Clifton GD, Berk MR, DeMaria AN. Effect of blood pressure and afterload on Doppler echocardiographic measurements of left ventricular systolic function in normal subjects. Am J Cardiol. 1989;64(14):905-8. 53. Bouzeghrane F, Reinhardt DP, Reudelhuber TL, Thibault G. Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis. Am J Physiol Heart Circ Physiol. 2005;289(3):H982-91. 54. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med. 1994;330(19):1335-41. 55. Wilson DG, Bellamy MF, Ramsey MW, et al. Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. Circulation. 1999;99(7):909-15. 56. Nataatmadja M, West J, West M. Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation. 2006;114(1 Suppl):I371-7. 57. Mariko B, Ghandour Z, Raveaud S, et al. Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells. Am J Physiol Cell Physiol. 2010;299(5):C977-87. 58. Jung B, Foll D, Bottler P, Petersen S, Hennig J, Markl M. Detailed analysis of myocardial motion in volunteers and patients using high-temporal-resolution MR tissue phase mapping. J Magn Reson Imaging. 2006;24(5):1033-9. 59. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25(4):543-67.
|